Identification of HLA-I restricted epitopes in six vaccine candidates of Leishmania tropica using immunoinformatics and molecular dynamics simulation approaches.


Journal

Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases
ISSN: 1567-7257
Titre abrégé: Infect Genet Evol
Pays: Netherlands
ID NLM: 101084138

Informations de publication

Date de publication:
11 2019
Historique:
received: 15 03 2019
revised: 01 07 2019
accepted: 04 07 2019
pubmed: 10 7 2019
medline: 28 5 2020
entrez: 9 7 2019
Statut: ppublish

Résumé

In spite of numerous studies on vaccination for various species of Leishmania, research on the development of an effective vaccine for L. tropica is very scarce. In silico epitope prediction is a new way to survey the best vaccine candidates. Here, we predicted the best epitopes of six L. tropica antigens with vaccine capability against this pathogen, using highly frequent HLA-I alleles. Based on the frequent HLA alleles, the protein sequences were screened individually using four different MHC prediction applications, namely SYFPEITHI, ProPredI, BIMAS, and IEDB. Several in silico assays including clustering, human similarity exclusion, epitope conservancy prediction, investigating in experimental records, immunogenicity prediction, and prediction of population coverage were performed to narrow the results and to find the best epitopes. The selected epitopes and their restricted HLA-I alleles were docked and the final epitopes with the lowest binding energy (the highest binding affinity) were chosen. Finally, the stability and the binding properties of the best epitope-HLA-I combinations were analyzed using molecular dynamics simulation studies. We found ten potential peptides with strong binding affinity to highly frequent HLA-I alleles that can be further evaluated as vaccine targets against L. tropica.

Identifiants

pubmed: 31284043
pii: S1567-1348(19)30172-8
doi: 10.1016/j.meegid.2019.103953
pii:
doi:

Substances chimiques

HLA Antigens 0
Protozoan Vaccines 0
Vaccines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

103953

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Alisha Akya (A)

Infectious Diseases Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.

Alireza Farasat (A)

Cellular and Molecular Research Center, Qazvin University of Medical Sciences, Qazvin, Iran.

Keyghobad Ghadiri (K)

Infectious Diseases Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.

Mosayeb Rostamian (M)

Infectious Diseases Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran. Electronic address: mosayeb.rostamian@kums.ac.ir.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH